Market Overview

20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

Curis, Inc. (NASDAQ:CRIS) shares increased by 61.48% to $1.97 during Wednesday's pre-market session.

Plus Therapeutics, Inc. (NASDAQ:PSTV) shares rose 18.45% to $2.76.

Alterity Therapeutics, Inc. (NASDAQ:ATHE) shares increased by 16.80% to $0.73.

InVivo Therapeutics Hldg, Inc. (NASDAQ:NVIV) shares increased by 15.46% to $2.39.

Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares moved upwards by 12.02% to $5.22.

Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) shares increased by 10.41% to $2.44. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares increased by 9.42% to $0.53. The most recent rating by H.C. Wainwright, on May 8, is at Neutral, with a price target of $0.

Allied Healthcare Prods, Inc. (NASDAQ:AHPI) stock moved upwards by 9.03% to $8.81.

Check-Cap, Inc. (NASDAQ:CHEK) stock moved upwards by 8.71% to $0.75. The most recent rating by H.C. Wainwright, on Apr 24, is at Buy, with a price target of $2.

Vermillion, Inc. (NASDAQ:VRML) stock increased by 8.46% to $4.87.

 

Losers

Immuron, Inc. (NASDAQ:IMRN) stock decreased by 32.65% to $13.47 during Wednesday's pre-market session.

Cardiovascular Systems, Inc. (NASDAQ:CSII) stock declined 11.36% to $34.02. The most recent rating by SVB Leerink, on Apr 28, is at Outperform, with a price target of $50.

Quidel, Inc. (NASDAQ:QDEL) shares fell 6.93% to $145.01. The most recent rating by JP Morgan, on May 12, is at Underweight, with a price target of $158.

Aptevo Therapeutics, Inc. (NASDAQ:APVO) stock fell 6.83% to $6.

Aethlon Medical, Inc. (NASDAQ:AEMD) shares fell 6.54% to $1.43.

Second Sight Medical, Inc. (NASDAQ:EYES) shares decreased by 5.84% to $1.45.

Precipio, Inc. (NASDAQ:PRPO) stock fell 4.55% to $1.05.

DBV Technologies, Inc. (NASDAQ:DBVT) stock declined 4.55% to $5.66. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.

Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares fell 4.11% to $3.50.

Ascendis Pharma, Inc. (NASDAQ:ASND) stock fell 3.98% to $136. The most recent rating by Morgan Stanley, on May 21, is at Overweight, with a price target of $181.

 

Related Articles (CRIS + PSTV)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas